Both in Biotechnology
Hemab Therapeutics Holdings vs Novavax
Over the past year COAG returned +5.2% and NVAX returned +7.0%; their daily moves had a correlation of 0.25.
COAG +5.2% NVAX +7.0%Growth of $1, one year, split-adjusted
| Metric | COAG | NVAX |
|---|---|---|
| Price | $41.45 | $10.08 |
| Market cap | $1.94B | $1.66B |
| Today | +2.55% | −3.72% |
| 1 month | +33.5% | −4.9% |
| 6 months | — | +25.4% |
| Year to date | — | +50.0% |
| 1 year | — | +20.3% |
| Revenue growth (YoY) | — | −76.3% |
| Gross margin | — | 74.9% |
| Net margin | — | −94.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.0× |
| Net cash | $457.5M | $422.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 79.8% |
| Short % of float | 20.4% | 30.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).